ArticleCureus2025
Anti-shivering Drug Influences the Characteristics of Electroencephalographic Shivering Noise During Targeted Temperature Management: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of a 75-year-old male patient who underwent targeted temperature management (TTM) following cardiopulmonary resuscitation and subsequently experienced uncontrolled shivering. Rocuronium was administered to alleviate shivering; however, the shivering recurred, necessitating continuous administration of dexmedetomidine. Analysis of the electroencephalography (EEG) recorded for neuromonitoring demonstrated that both pharmacological agents significantly reduced the power of the alpha and beta waves at 10 and 60 minutes post-administration. Dexmedetomidine also influenced the delta and theta waves, coinciding with the cessation of shivering, whereas muscle relaxants exhibited minimal effects on these frequency bands. These findings suggest that shivering-induced noise causing EEG changes is drug-dependent and predominantly affects high-frequency regions, potentially impacting the neurological prognosis predictions and detection of nonconvulsive status epilepticus (NCSE). This case illustrates the need to recognize the effects of shivering and anti-shivering medications on EEG monitoring during post-resuscitation care. Further research is warranted to evaluate the impact of these factors on EEG-based prognostication and NCSE detection, and to optimize strategies for managing shivering-induced artifacts during TTM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.